Neuroprotective Effect of Swertiamarin in a Rotenone Model of Parkinson’s Disease: Role of Neuroinflammation and Alpha-Synuclein Accumulation-Reference-Cited by-同舟云学术

Neuroprotective Effect of Swertiamarin in a Rotenone Model of Parkinson’s Disease: Role of Neuroinflammation and Alpha-Synuclein Accumulation

Published:2022-12-14 Issue:1 Volume:6 Page:40-51
ISSN:2575-9108
Container-title:ACS Pharmacology & Translational Science
language:en
Short-container-title:ACS Pharmacol. Transl. Sci.

Author:

Sharma Monika¹,Malim Fehmina Mushtaque¹,Goswami Ashutosh²,Sharma Nishant¹,Juvvalapalli Sai Sowmya²,Chatterjee Sayan¹,Kate Abhijeet S.²,Khairnar Amit¹³^ORCID

Affiliation:

1. Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad, Gujarat 382355 India

2. Department of Natural Products, National Institute of Pharmaceutical Education and Research (NIPER), Ahmedabad, Gujarat 382355 India

3. International Clinical Research Center, St. Anne’s University Hospital Brno, Brno 656 91 Czech Republic

Funder

European Commission

Department of Biotechnology, Ministry of Science and Technology, India

National Institute of Pharmaceutical Education and Research, Ahmedabad

Department of Chemicals and Petrochemicals, Ministry of Chemicals and Fertilizers

Publisher

American Chemical Society (ACS)

Subject

Pharmacology (medical),Pharmacology

Link

https://pubs.acs.org/doi/pdf/10.1021/acsptsci.2c00120

Reference57 articles.

1. Motor and Non-Motor Symptoms in Parkinson’s Disease: Effects on Quality of Life

2. Effects of Exercise on Non-motor Symptoms in Parkinson’s Disease

3. ‘Rejuvenation’ protects neurons in mouse models of Parkinson’s disease

4. Modeling Parkinson’s Disease With the Alpha-Synuclein Protein

5. An update on the diagnosis and treatment of Parkinson disease

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Computational discovery of AKT serine/threonine kinase 1 inhibitors through shape screening for rheumatoid arthritis intervention;Molecular Diversity;2024-07-06

2. Chemical composition and studying the possible neuroprotective effect of iridoids-rich fraction from Pentas lanceolata leaves using rotenone model of Parkinson’s disease in mice;Inflammopharmacology;2024-07-04

3. Chemical composition and studying the possible neuroprotective effect of iridoids-rich fraction from Pentas lanceolata leaves using rotenone model of Parkinson’s disease in mice;2024-05-07

4. Recent advances in natural products targeting α-synuclein aggregation or clearance in Parkinson's disease;European Journal of Medicinal Chemistry Reports;2023-12

5. Analgesic effect of Centaurium erythraea and molecular docking investigation of the major component swertiamarin;Natural Product Research;2023-11-10